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Although lentiviruses like HIV-1 are able to infect non-dividing cells, particular resting cells such as non-stimulated primary peripheral blood
mononuclear cells (PBMC) are resistant to infection. In contrast to other lentiviruses, SIVsmmPBj can replicate in non-stimulated PBMC.
Moreover, SIVsmmPBj-derived, but not HIV-1-derived, replication-incompetent vectors enable gene transfer into G0-arrested human cell lines and
primary human monocytes. Here, we demonstrate that transduction of G0-arrested cell lines by SIVsmmPBj-derived vectors is independent of the
viral accessory proteins Vif, Vpx, Vpr, or Nef. In contrast, for the transduction of primary human monocytes, the Vpx protein proved to be
essential. However, trans-complementation of HIV-1 vectors with SIVsmmPBj Vpx did not provide the property of gene transfer into monocytes.
Taken together, these data indicate that Vpx is essential for the infection of primary monocytes by SIVsmmPBj. Additionally, further genome
functions besides the accessory proteins are required for the particular capacity of SIVsmmPBj in transduction or infection events.
© 2007 Elsevier Inc. All rights reserved.Keywords: SIVsmmPBj; Monocytes; Quiescent cells; Accessory proteins; Lentiviral infectionIntroduction
The capacity of lentiviruses to infect non-dividing cells has
been attributed to mechanisms allowing active import of viral
DNA into the nucleus, whereas gamma-retroviruses are
presumed to need the breakdown of the nuclear membrane
during mitosis for the establishment of the provirus and
replication (Lewis and Emerman, 1994). However, inconsis-
tencies about the viral factors contributing to the active nuclear
entry of lentiviral genomes still exist. Some of the lentiviral
proteins, e.g. the accessory proteins Vpr (Fouchier et al., 1998;
Heinzinger et al., 1994) and Vpx (Belshan and Ratner, 2003;
Pancio et al., 2000), the matrix (Bukrinsky et al., 1993) and the
integrase (Gallay et al., 1997) proteins, contain nuclear
localization signals (NLSs) and are described as components⁎ Corresponding author. Fax: +49 6103 771255.
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doi:10.1016/j.virol.2007.03.008of the viral preintegration complex (PIC). The central
polypurine tract (cPPT) is thought to mediate infection of
resting cells by formation of a triple-stranded DNA flap
regulating nuclear entry (Zennou et al., 2000). It can be assumed
that additional functions, e.g. of the lentiviral regulatory or
accessory genes, may also contribute to the replication ability in
non-dividing cells.
Remarkably, particular non-dividing cells are not readily
permissive for cell entry and subsequent replication of
lentiviruses like HIV-1. Such cells include unstimulated T-
cells (Pierson et al., 2002; Zack et al., 1990) and primary
monocytes (unpublished data), which are regarded to be in the
G0-phase of the cell cycle. This may indicate that the level of
cell activation in these and other quiescent cells is not sufficient
to permit lentivirus entry and replication. The inability of
lentiviruses to infect cells in the G0-phase of the cell cycle is
reflected by the inability of replication-incompetent lentiviral
vectors to transduce G0-arrested cell lines, pointing to a block
already in early steps of infection.
In contrast to other lentiviruses, the enteropathic simian
immunodeficiency virus strain SIVsmmPBj from sooty man-
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replicate in non-stimulated peripheral blood mononuclear cells
(PBMC) (Fultz, 1991). Moreover, we recently demonstrated
that a replication-incompetent vector derived from SIVsmmPBj
enables efficient transduction of G0-arrested cell lines and
primary human monocytes which are also in G0-phase of the
cell cycle (Muhlebach et al., 2005). This capacity offers the
chance to study the requirements in early steps of infection of
quiescent cells using a non-replicative system. PCR analysis of
vector DNA indicated that nuclear entry and chromosomal
integration of SIVsmmPBj proviral DNA occurs in primary
non-stimulated human monocytes, whereas gene transfer by
HIV-1-derived vector is blocked before nuclear entry (Muhle-
bach et al., 2005; Neil et al., 2001).
The reasons for this remarkable difference between HIV-1
and SIVsmmPBj have to be elaborated. Besides others, an
impact of one or several of the lentiviral accessory genes vif,
vpr, vpu, vpx, or nef, which are known to have a variety of
complex functions in the regulation of virus–cell interactions
(Anderson and Hope, 2004; Emerman and Malim, 1998), could
be an explanation. Especially the nef gene, which has been
reported to play an essential role in the particular pathogenicity
of SIVsmmPBj (Du et al., 1995; Novembre et al., 1996), was
suspected to be responsible for the transduction capacity of
SIVsmmPBj-derived vectors. However, using Nef-deleted
vectors we showed that Nef is not required for this property
(Muhlebach et al., 2005). Whereas Vif and Vpr proteins are
encoded by all primate lentiviruses known, Vpu is encoded only
by HIV-1 (Strebel et al., 1988), and Vpx is unique to the HIV-2/
SIVsmm/SIVmac group of lentiviruses (Belshan et al., 2006;
Henderson et al., 1988; Mahalingam et al., 2001). The Vpx
protein is important for nuclear import of the viral preintegra-
tion complex (Belshan and Ratner, 2003; Fletcher et al., 1996;
Wu et al., 1994), especially in non-dividing cells (Belshan et al.,
2006; Fultz, 1991; Pancio et al., 2000). Remarkably, the Vpx of
SIVsmmPBj has been reported to be essential for the replication
in primary macrophages from macaques and to play a central
role in local virus replication and recruitment of uninfected cells
in vivo (Hirsch et al., 1998).
Here we have used a non-replicative SIVsmmPBj vector
system to analyze the role of viral accessory genes in early steps
of infection of quiescent cells. We developed SIVsmmPBj
envelope gene-knockout vectors with additional deletions of
one or more of the accessory proteins Vif, Vpx, Vpr, and Nef, to
analyze their influence on the transduction of quiescent cells.
Whereas none of these proteins was required for the transduc-
tion of G0-arrested osteosarcoma cells or diploid fibroblast, the
Vpx protein turned out to be essential for the transduction of
primary human monocytes.
Results
Generation of SIVsmmPBj accessory gene-knockout vectors
To analyze the role of viral accessory proteins in early
infection steps, PBj vector variants were generated containing
functional knockouts of one or all of the accessory genes vif,vpx, vpr or nef. All constructs based upon the env-deleted
plasmid pPBjΔenv derived from SIVsmmPBj1.9 (Muhlebach
et al., 2005). To avert translation, the start-ATGs of the
accessory genes were mutated, and at least one additional stop
codon was inserted within the same reading frame while
preserving amino acid sequences of overlapping reading frames
(Figs. 1A, B). Knockouts of single accessory genes resulted in
vector constructs pPBjΔEΔvif, pPBjΔEΔvpx, pPBjΔEΔvpr,
or pPBjΔEΔnef, whereas the construct harboring knockouts of
all four accessory genes was designated pPBj4xko. VSV-G
pseudotyped vectors were generated and used for single-round
infection of target cells. Since these vectors did not carry a
marker gene, transduction was detected by in situ immune
staining (IPA) of viral proteins. Titration of vectors on HT1080
cells revealed titers of about 5×106 transducing units (TU)/ml
for each of the various knockout vectors (data not shown).
To prove successful abrogation of accessory gene transla-
tion, vector particles were examined for presence of accessory
proteins using Western blot analysis (Fig. 1C). As expected,
presence of all accessory proteins was demonstrated in vector
particles generated by the parental PBjΔenv vector encoding
Vif, Vpx, Vpr, and Nef. In contrast, the respective protein was
not detected in vector preparations of the single knockout
vectors, and none of the accessory proteins was detected in
PBj4xko vector particles, indicating efficient translational
knockout of these genes.
Transduction of growth-arrested GHOST/CD4-CXCR4 and
α-1 cells is independent of the viral accessory genes
Target cells GHOST/CD4-CXCR4 or α-1 were arrested in
the G1/S- or G0-phase of the cell cycle. Successful arrest was
confirmed by determination of the DNA content as described
previously (Muhlebach et al., 2005) (data not shown).
Arrested cells as well as proliferating cells were transduced
with VSV-G pseudotyped HIV-1-, MLV-, PBjΔenv- or PBj-
knockout vectors at various dilutions. Two days later,
transduced cells were analyzed by immune staining of viral
gene products (IPA) or, in case of GHOST/CD4-CXCR4 cells,
by microscopic analysis of Tat-induced endogenous GFP
expression. Transduction achieved by the β-galactosidase-
transferring MLV vectors was detected by X-gal staining.
Relative transduction efficiencies measured in three indepen-
dent experiments are shown in Fig. 2, where transduction
efficiencies of each vector variant in proliferating cells were
set as 100%. As expected (Muhlebach et al., 2005), the MLV-
derived vector transduced only proliferating cells, and the
HIV-1 vector transduced proliferating as well as G1/S-arrested
cells. Remarkably, all PBj-derived vectors mediated efficient
transduction of G0-arrested cells irrespective of the expression
of one or all of the accessory genes. A slight reduction of the
transduction efficiency of each of the PBj knockout vectors
compared to that of the PBjΔenv vector expressing all
accessory genes was observed in GHOST cells only. Thus, we
concluded that none of the four accessory proteins of
SIVsmmPBj was required for the transduction of G0-arrested
cells.
Fig. 1. Knockout of SIVsmmPBj accessory genes. (A) Schematic representation of the genomes of SIVsmmPBj-derived knockout vectors. The positions of the
knockout modifications for each accessory gene are indicated by asterisks. Top: Single and 4-fold knockout vectors PBjΔEΔvif, PBjΔEΔvpx, PBjΔEΔvpr,
PBjΔEΔnef and PBj4xko devoid of a marker gene. Bottom: Single Vpx-knockout vector pPBjΔEΔVpx-EGFP, and 4-fold knockout vector PBj4xko-EGFP carrying an
egfp expression cassette. RRE, Rev-responsive element;Ψ, packaging signal; LTR, long terminal repeat. (B) Nucleic acid and amino acid sequences of the accessory
genes vif, vpx, vpr, and nef of SIVsmmPBj before and after modification of the start codon and insertion of one or two additional stop codons. Base exchanges are
highlighted by an arrow and shown in bold. In addition, the amino acid sequences of the respective overlapping reading frames are shown in grey. (C) Western blot
analysis of concentrated knockout vector particles. Antibodies or sera used for detection of the accessory gene products are indicated below. NC, negative control.
Fig. 2. Transduction efficiency of SIVsmmPBj knockout vectors in cells arrested in different phases of the cell cycle. GHOST/CD4-CXCR4 (left) or α-1 (right) cells
arrested in the G1/S- or G0-phase as indicated were infected with the VSV-G-pseudotyped SIVsmmPBj, HIV-1, or MLV vectors indicated below and analyzed for viral
gene expression 3 days later. The relative transduction efficacy is expressed as the percentage of the transduction efficacy obtained by each vector in proliferating
GHOST/CD4-CXCR4 or α-1 cells, respectively, which was set to 100%. Mean of three independent experiments.
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primary human monocytes
Next, we evaluated the capacity of a PBj vector lacking all
accessory genes to transduce primary human monocytes that are
considered to stay in the G0-phase of the cell cycle. To allow
easy analysis of gene transfer, the egfp-transferring vectors
PBjΔE-EGFP or PBj4xko-EGFP (Fig. 1A) were used. When
pseudotyped with VSV-G and titrated on HT1080 cells, both
vectors achieved titers of up to 1×107 TU/ml (data not shown).
Primary human monocytes were obtained by negative depletion
from PBMC of healthy human donors and were analyzed by
FACS for the expression of surface markers CD14 and CD86.
Routinely, the purity of the monocyte population was about
90% (data not shown). These cells were transduced at various
days post isolation at an moi of 5 using PBj4xko-EGFP,
HIVNL4-3ΔE-EGFP, or PBjΔE-EGFP vectors (Fig. 3). The
PBjΔE-EGFP vector harboring all four accessory proteins was
able to transduce monocytes already on day 1 post isolation
with an efficiency of nearly 20% and reached about 40%
transgene-positive monocytes on day 4, whereas HIVNL4-3ΔE-
EGF failed to transduce monocytes during the first days after
isolation and transduced cells only after day 4 at low efficiency,
thus confirming previous results (Muhlebach et al., 2005; Neil
et al., 2001). However, the PBj4xko-EGFP vector revealed
similar results as the HIV-1 vector, indicating that at least one of
the accessory proteins is required for the transduction of
primary human monocytes.
Vpx is required for the transduction of primary human
monocytes
Previously published data indicated a central role of Vpx in
the infection of primary macrophages of macaques with
SIVsmmPBj (Hirsch et al., 1998). Thus, we analyzed the
need for Vpx in transduction of monocytes with PBj vectors.Fig. 3. Transduction efficiency of PBj4xko-EGFP lacking all accessory gene
products in primary human monocytes. Percentage of egfp-expressing cells
transduced at various days after monocyte isolation using different vectors as
indicated and assayed 1 week later. Means of three different donors from one
representative out of three independent experiments are shown.Two Vpx expression constructs were generated and used for
complementation of PBj4xko-EGFP (Fig. 4A). Plasmid pwt-
Vpx codes for the unmodified SIVsmmPBj Vpx, whereas a
hemagglutinin (HA)-tag was fused to the N-terminus of Vpx in
plasmid pHA-Vpx. VSV-G-pseudotyped PBj4xko-EGFP vec-
tor particles were generated in the presence of either of the Vpx
expression plasmids. To verify packaging of the Vpx proteins,
vector particles were purified and evaluated for the presence of
Vpx proteins using Western blot analysis. As controls, PBjΔE-
EGFP and PBj4xko-EGFP VSV-G pseudotype vector particles
were generated in the absence of a vpx expression construct.
Vpx was detected in PBj4xko-EGFP vector particles comple-
mented with wt-Vpx and in the PBjΔE-EGFP vector particles,
but not in the uncomplemented PBj4xko-EGFP vector (Fig.
4B). The HA-tagged Vpx could be detected using an anti-HA-
antibody, although visualization of this tagged protein by the
anti-HIV-2-Vpx antibody 6D2.6 was hardly possible. This may
be due to an influence of the HA-tag on the binding of the
antibody to its epitope, since untagged SIVsmmPBj Vpx was
readily detected (Fig. 1C). Nevertheless, the detection of Vpx in
vector particles by any antibody indicated incorporation of both
of the complementing Vpx proteins. Remarkably, the amount of
Vpx incorporated into vector particles was regularly lower
when Vpx was provided in trans by a separate expression
plasmid compared to expression of vpx from the vector genome.
To examine the capacity of Vpx-complemented vectors for
the transduction of primary human monocytes, successive
transduction experiments were carried out as described before
using uncomplemented PBjΔE-EGFP and PBj4xko-EGFP
vectors as controls (Fig. 4C). PBj4xko-EGFP vectors comple-
mented with any of the Vpx proteins were able to transduce
primary monocytes already on day 1 after isolation with similar
efficiency as the PBjΔE-EGFP vector containing all accessory
genes. Vectors supplemented with the HA-tagged Vpx were less
efficient, possibly due to sterical problems evoked by the HA-
tag. Nevertheless, both Vpx variants gave rise to efficient
transduction of primary human monocytes, which indicates a
pivotal role of Vpx in early steps of infection of monocytes.
In theory, one of the other accessory proteins besides Vpx
may also be able to restore the transduction capacity of a PBj
vector lacking all of the accessory genes. To test this possibility,
the transduction capacity of the egfp-transferring vector
pPBjΔEΔVpx-EGFP, which lacks Vpx but carries Vif, Vpr,
and Nef, was investigated. When pseudotyped with VSV-G and
titrated on HT1080 cells, this vector achieved titers of up to
3×107 TU/ml after concentration (data not shown). However,
successive transduction of monocytes as described before
revealed that this vector was not able for gene transfer into
monocytes, whereas supplementation with Vpx resulted in
efficient transduction (Figs. 4D, E). Obviously, presence of Vif,
Vpr, or Nef is not sufficient to substitute for this function of Vpx.
Vector integration into the monocyte host cell genome is
abrogated in the absence of Vpx
HIV-1 and HIV-1-derived vectors are able to enter mono-
cytes and to start reverse transcription of their genome, but fail
Fig. 4. Supplementation of the SIVsmmPBj knockout vectors PBj4xko-EGFP or pPBjΔEΔVpx-EGFP with Vpx in trans. (A) Schematic representation of vpx
expression constructs indicated. HA, hemagglutinin tag; CMV, CMV promoter; pA, bovine growth hormone polyadenylation signal. (B) Western blot analysis of
vectors generated in the presence of vpx expression constructs as indicated above. Antibodies used for detection are indicated below. NC, negative control. (C)
Transduction of primary human monocytes using Vpx-supplemented PBj4xko-EGFP vector. Percentage of egfp-expressing cells transduced at various days after
monocyte isolation using vectors with or without supplementation with wt-Vpx or HA-Vpx as indicated. Means of three different donors from one representative out of
three independent experiments are shown. (D) Western blot analysis of Vpx knockout vector pPBjΔEΔVpx-EGFP generated with or without Vpx complementation as
indicated above. Antibodies used for detection are indicated below. (E) Transduction of primary human monocytes using Vpx knockout vector pPBjΔEΔVpx-EGFP
generated with or without wt-Vpx complementation as indicated. Percentage of egfp-expressing cells transduced at various days after monocyte isolation. Means of
three different donors.
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contrast, PBj-derived vectors containing all accessory genes
were previously shown to allow nuclear transport and genome
integration (Muhlebach et al., 2005). To further characterize the
influence of Vpx on the block of infection, the fate of the
genomes of Vpx-deficient and Vpx-carrying vectors was
compared. Genomic DNA was purified from mitotic HT1080
cells or primary human monocytes 4 days after transduction
with Vpx-supplemented or unsupplemented PBj4xko-EGFP
vectors. To avoid DNA carryover from packaging cells, vector
preparations had been treated with DNase before transduction.
Purified DNAwas analyzed by a two-step Alu PCR method forthe integration of vector genome. Chromosomal integration is
indicated by this method, if a preceding Alu PCR is
significantly increasing the virus-specific signal of the second
amplification step. Using this assay, integration of vector DNA
was detected in monocytes exclusively after transduction with
the Vpx-complemented PBj4xko-EGFP vector, whereas inte-
gration of the uncomplemented PBj4xko-EGFP vector was not
detected (Fig. 5A). Furthermore, we analyzed genomic DNA of
monocytes for the presence of two-LTR circles, since formation
of two-LTR circles occurs in the nucleus and is therefore
commonly used as a marker for the nuclear import of retroviral
DNA (Neil et al., 2001). A PCR fragment spanning the LTR/
Fig. 5. Analysis of vector DNA present in cells transduced with SIVsmmPBj-derived vectors. Monocytes or HT1080 cells were transduced using the vectors with or
without Vpx supplementation as indicated above and analyzed by PCR 4 days post transduction. Expected length of amplification products is indicated. ut,
untransduced. (A) Amplification products of a two-step Alu PCR for detection of chromosomally integrated vector DNA. Alu, amplification products after two rounds
of amplification; w/o Alu, amplification products of virus-specific PCR (second round) without previous Alu PCR. (B) Amplification products of a PCR for detection
of two-LTR circles. (C) Control; amplification of a fragment of the human β-actin gene. (D) Amplification products of a PCR for detection of GFP transgene sequences
indicative for reverse transcription of vector RNA and β-actin control.
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monocytes transduced with Vpx-complemented PBj4xko-
EGFP vectors two-LTR circles were detectable (Fig. 5B). At
last, we examined the occurrence of reverse transcription of
vector genomes. DNA was isolated from monocytes 4 h after
transduction and amplified using primers specific for the
transduced marker gene egfp. Successful amplification indi-
cated that reverse transcription of both vectors had occurred
(Fig. 5C), suggesting an infection or transduction block of Vpx-
negative vectors after reverse transcription, similar as for HIV-1
(Muhlebach et al., 2005; Neil et al., 2001). In conclusion,
completion of nuclear import and integration of PBj vector
DNA but not reverse transcription of RNAwas found to depend
on the viral Vpx protein in monocytes.
HIV-1 vectors supplemented with SIVsmmPBj Vpx are not able
to transduce monocytes
HIV-1-derived vectors do not encode Vpx and are not able
for infection or transduction of primary human monocytes.Therefore, we analyzed whether SIVsmmPBj Vpx is able to
confer the ability of monocyte transduction to HIV-1-derived
vectors. Replication-incompetent HIV-1 particles based on env-
deleted HIV-1 (pNL4-3ΔE-EGFP) were pseudotyped with VSV-
G and generated in the presence of HA-tagged SIVsmmPBj
Vpx. The presence of Vpx in resulting particles was examined
using Western blot analysis (Fig. 6C). However, lack of specific
bands indicated that Vpx was not incorporated into HIV-1
particles.
Therefore, we attempted to enable incorporation of
SIVsmmPBj Vpx into HIV-1 vector particles by modifying
vector components. It has previously been published that Vpx
of SIVsmm (SIV from sootey mangabey monkey), SIVmac
(SIV from rhesus macaque), or HIV-2 is incorporated into
particles via an interaction with the p6 domain of the Gag
proteins (Accola et al., 1999; Jin et al., 2001; Selig et al., 1999).
On the other hand, HIV-1 incorporates the accessory protein
Vpr via an interaction with the same domain (Jenkins et al.,
2001). Thus, we tried to enable packaging of SIVsmmPBj Vpx
by insertion of the respective binding sites of SIVsmmPBj p6
Fig. 6. Supplementation of HIV-1-derived vectors with SIVsmmPBj Vpx. (A) Amino acid sequence comparison of Gag-p6 of SIVsmmPBj and HIV-1. Grey boxes
show identical amino acids. The 3′ part overlaps with the reading frame of the protease as indicated by the arrow. (B) Schematic representation of HIV-1-derived vector
genomes. Top: HIVNL4-3ΔE-EGFP. Below: magnification of the modified gag-p6 regions of HIV-LC-EGFP. The p6 portion derived from SIVsmmPBj and inserted
into HIV-1 vector is marked as grey box. RRE, Rev-responsive element;Ψ, packaging signal; LTR, long terminal repeat. (C) Western Blot analysis of concentrated and
purified HIV-1 vector particles with or without Vpx supplementation as indicated above and detected using the antibodies as indicated below. NC, negative control.
(D) Transduction of primary human monocytes using Vpx-supplemented HIV-1 vectors. Percentage of egfp-expressing cells transduced at different days after
monocyte isolation using Vpx-supplemented HIV-LC-EGFP and control vectors as indicated and assayed 1 week later. Means of three different donors from one
representative out of three independent experiments are shown. (D) PCR amplification of DNA extracted from monocytes for detection of GFP transgene sequences
indicative for reverse transcription of vector RNA, and β-actin control.
336 N. Wolfrum et al. / Virology 364 (2007) 330–341into HIV-1 p6. The p6 domains of HIV-1 and SIVsmmPBj
exhibit profound amino acid sequence differences (Fig. 6A).
However, some homologies are located in the 5′- and the 3′-part
of the p6 domains of each virus, respectively, but the regions in-
between are highly distinct. To achieve incorporation of Vpx
into HIV-1 particles, an HIV-1 packaging construct variant
designated pHIV-LC-EGFP was generated by inserting amino
acids 22–50 of SIVsmmPBj p6 between amino acids 17 and 19
of the HIV-1 p6 domain of pNL4-3ΔE-EGFP (Fig. 6B), thereby
replacing Gly18. VSV-G pseudotyped vector particles were
generated in the presence of HA-tagged Vpx. Using Western
blot analysis, Vpx could be detected in HIV-LC-EGFP vector
particles (Fig. 6C), demonstrating incorporation of SIVsmmPBj
Vpx into HIV-1 particles. Transduction experiments performed
on HT1080 cells revealed that HIV-LC-EGFP particles wereinfectious and led to titers comparable to those obtained using
the unmodified HIV vector (up to 106/ml).
To examine the transduction capacity of Vpx-supplemented
HIV-1 vectors, monocytes were isolated and transduced with
HIV-LC-EGFP vectors complemented with the N-terminally
HA-tagged SIVsmmPBj Vpx. These vectors were unable to
transduce primary human monocytes before day 4 after isolation,
whereas the control vector PBjΔE-EGFP revealed a transduction
capacity similar as known from the previous experiments (Fig.
6D). We also used the unmodified SIVsmmPBj Vpx (wt-Vpx)
for the complementation of the HIV-LC-EGFP vectors, but no
transduction of primary monocytes comparable to PBj vectors
was detected (data not shown). However, amplification of egfp
sequences from monocytes transduced with HIV-LC-EGFP
vectors complemented with HA-tagged Vpx (Fig. 6E) points to
337N. Wolfrum et al. / Virology 364 (2007) 330–341a transduction block after reverse transcription similar as
suggested above for wt HIV-1 or Vpx-lacking PBj vectors. The
failure in transducing primary human monocytes using the Vpx-
complemented HIV-LC-EGFP vector, which was infectious for
dividing cells, indicated that Vpx is not the only factor required
for monocyte transduction. Obviously, other components of
SIVsmmPBj besides Vpx are required to allow transduction of
these cells.
Discussion
In this work, we used non-replicating lentiviral vector va-
riants derived from SIVsmmPBj in single-round infections as a
model to analyze the impact of lentiviral accessory proteins on
early steps of infection of quiescent cells. The accessory
proteins are assumed to play no essential role for the trans-
duction of non-dividing cells using common lentiviral vectors,
since they can be deleted without losing the transduction ability
in particular cell types, even though transduction efficiency is
reduced (Zufferey et al., 1997). Several quiescent cells such as
cells arrested in the G0-phase of the cell cycle cannot be
transduced by those vectors, regardless of the presence or
absence of the accessory proteins (Pierson et al., 2002; Zack et
al., 1990). However, we recently demonstrated that a lentiviral
vector derived from the SIVsmmPBj strain is able to transduce
G0-arrested cells and primary monocytes, whereas transduction
of these cells by HIV-1-derived vectors was blocked at a step
prior to nuclear entry of proviral DNA (Muhlebach et al., 2005;
Neil et al., 2001). The basis of this exceeding capability of
SIVsmmPBj vectors remained unclear, but could possibly be
attributed to distinct functions of the SIVsmmPBj genome.
Since all comparative transduction experiments have been done
using SIVsmmPBj- and HIV-1-derived pseudotype vectors
carrying the same envelope protein VSV-G, it is obvious that
the lentiviral envelope is not crucial in this context. Besides
other components like the LTRs, or the gag and the pol genes,
the viral accessory genes, which are known to be involved in
regulation of virus–cell interactions, were taken into account as
genetic determinants of the specific capacity of PBj-derived
vectors. The most promising candidate was the nef gene since it
had been associated with the particular replication capacity of
SIVsmmPBj in unstimulated primary lymphocytes and the
specific pathogenicity of this virus (Du et al., 1995; Novembre
et al., 1996). However, using Nef-deleted vectors, we could
exclude a role of Nef in the transduction of quiescent cells
(Muhlebach et al., 2005).
Here, we analyzed a possible role of the remaining accessory
proteins Vif, Vpr, and Vpx by analyzing the transduction
capacity of respective knockout vectors. To avoid modification
of overlapping reading frames, the accessory genes were not
physically deleted, but translation was abrogated by mutation of
the start codons and introduction of stop codons without
changing the amino acid sequences of the overlapping reading
frames. Successful abrogation of gene expression could be
shown by Western blot analysis. Transduction experiments
using these vectors revealed that none of the accessory proteins
Vif, Vpr, Vpx or Nef alone was essential for the transduction ofG0-arrested human cell lines or diploid fibroblasts, although the
transduction efficiency was slightly diminished in fibroblasts
compared to that of the vector containing all accessory genes.
The theoretical possibility that a putative function of one of the
accessory proteins could be substituted by that of another was
also excluded, since a vector in which transcription of all four
genes was inhibited revealed similar transduction efficiency.
Thus, it can be emphasized that none of the four accessory
proteins of SIVsmmPBj is responsible for the circumvention of
the block of transduction by HIV-1 vectors present in G0-
arrested cell cultures.
In contrast, transduction experiments using the PBj4xko-
EGFP vector or a Vpx-knockout vector carrying Vif, Vpr, and
Nef, and complementation with Vpx revealed that this protein is
essential for the transduction of freshly isolated, primary human
monocytes, which were shown to be in the G0-phase of the cell
cycle at least until day 3 after isolation (Muhlebach et al., 2005).
The other accessory proteins are not required for this feature.
PCR analysis of proviral DNA indicated that the infection block
of Vpx-negative vectors occurred after reverse transcription of
viral RNA but prior to nuclear entry, similar as shown for HIV-1
vectors. In contrast, the Vpx-complemented PBj4xko-EGFP
vector enabled nuclear transport and proviral integration as the
replication-incompetent wild type PBjΔE-EGFP vector.
The crucial question arose whether Vpx of SIVsmmPBj is
sufficient for the transduction of monocytes by lentiviral vectors
in general, or whether Vpx is needed in this specific cell type in
addition to an unidentified further property of PBj. Remarkably,
Vpx of SIVsmmPBj and other viruses of the HIV-2/SIVsmm/
SIVmac group is supposed to play an essential role for viral
replication in macrophages (Hirsch et al., 1998). For monocyte-
derived dendritic cells, which can be transduced with HIV-1 or
SIVmac-derived vectors, it has been shown that the efficiency
of transduction can be enhanced by Vpx of SIVmac (Mangeot et
al., 2002; Negre et al., 2000). Obviously, Vpx plays an impor-
tant role in viral infection, replication or transduction using this
virus group in cells of the monocyte lineage in general, not only
in quiescent monocytes. Therefore it seems probable that a
specific SIVsmmPBj function is required to enable infection of
quiescent monocytes.
To analyze if SIVsmmPBj Vpx is sufficient to mediate
monocyte transduction using lentiviral vectors, we tried to
complement HIV-1 vectors with the Vpx protein of SIVsmmPBj.
Successful transduction of monocytes by Vpx-supplemented
HIV-1-vectors would exclude the need for additional PBj
elements. However, cotransfection of packaging cells with the
HIV-1 vector system and an expression plasmid for wild type
SIVsmmPBj Vpx did not result in incorporation of Vpx into
HIV-1 vector particles as demonstrated by Western blot analysis.
Therefore, the gag gene of the HIV-1 packaging vector was
modified. The Vpx interaction domain within p6 of SIVsmmPBj
was inserted into HIV-1 p6. Whereas Vpx was successfully
incorporated into these modified HIV-1 vector particles, this
vector was incapable of transducing primary human monocytes.
PCR analysis revealed that the transduction block occurred after
reverse transcription of vector RNA, similar to that described for
HIV-1 wt vectors (Muhlebach et al., 2005; Neil et al., 2001) or
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plementation of HIV-1 vectors with the Vpx protein of
SIVsmmPBj is not sufficient to confer this property. It can be
assumed that either an additional feature of SIVsmmPBj besides
Vpx is necessary for the transduction of human monocytes, or
interactions of Vpx with other viral components, e.g., with
components of the viral preintegration complex, are not
preserved in the HIV-1 vector. For the first alternative, it can
be speculated that this may be the same factor which allows
transduction of cell lines arrested in G0-phase of the cell cycle.
A further possibility would be that the amount of Vpx is
crucial for the transduction of primary human monocytes by
lentiviral vectors. In SIVsmmPBj particles, the amount of Vpx
was comparatively low when provided in trans by cotransfec-
tion with a vpx expression plasmid. However, the amount in
HIV-1 vector particles, although clearly detectable, may still be
lower and therefore possibly too low to mediate efficient
transduction of monocytes. Goujon et al. (2006) have recently
shown that preincubation of monocyte-derived dendritic cells
with non-infectious virus-like particles derived from SIVmac
containingVpx increases the efficiency of transduction byHIV-1
lentiviral vectors up to 10-fold. Whether there is a higher
amount of Vpx “transported” into the respective cells using
those virus-like particles, and whether this also facilitates
transduction of primary human monocytes remains elusive.
Altogether, we have demonstrated that the accessory proteins
of SIVsmmPBj are not responsible for the ability of transducing
quiescent cells (with the exception of Vpx in the specific case of
monocytes), but the molecular basis for this capacity still
remains to be further investigated. It may be speculated that in
quiescent cells either factors necessary for the early infection
steps of lentiviruses others than SIVsmmPBj are missing, or that
SIVsmmPBj is resistant against particular antiviral factors
present in these cells. Further analyses are necessary to define
the specific impact of viral functions besides the accessory
proteins, e.g. of the Gag or the Pol proteins.
Materials and methods
Plasmids
Env-deficient SIVsmmPBj vector constructs pPBjΔenv and
pPBjΔE-EGFP were described previously (Muhlebach et al.,
2005). For the generation of the accessory gene knockout-
constructs pPBjΔEΔvif, pPBjΔEΔvpx, pPBjΔEΔvpr, or
pPBjΔEΔnef, the quick-change site-directed mutagenesis kit
(Stratagene, La Jolla, CA, USA) was used to introduce mutations
into pPBjΔenv destroying the start codon and inserting at least
one additional stop codon into the respective accessory genes
as shown in Figs. 1A and B. vif, vpx, or vpr mutants were
subcloned as internal BclI–BstZ17I DNA fragments, the nef
mutant as BsaBI–NotI DNA fragment. Mutagenized genes were
reinserted into the pPBjΔenv proviral vector. The pPBj4xko
construct was generated by amplifying the respective gene
fragments of the single knockout-constructs which were
subsequently fused by overlap extension PCR. PCR-fragments
containing the mutated vif, vpx, and vpr genes were reinsertedinto the pPBjΔenv vector using BclI and BstZ17I restriction
sites. The nef-mutation was reinserted by replacing the intact
gene using the restriction sites BsmBI and NotI. The egfp-
transferring construct pPBj4xko-EGFP was generated by insert-
ing the CMV promoter/egfp expression cassette of pEGFP-N1
(Clontech Laboratories, Inc., Palo Alto, CA, USA) 3′ of the rev
responsive element (RRE) via the restriction site SnaBI. The
egfp-transferring construct pPBjΔEΔVpx-EGFP was generated
by insertion of the BstZ17I/NotI-fragment of pPBjΔE-EGFP
containing the 3′ end of the vector genome harboring the CMV
promoter/egfp expression cassette into the respective sites of the
pPBjΔEΔvpx plasmid.
SIVsmmPBj Vpx expression construct pwt-Vpx was
generated by PCR amplification of SIVsmmPBj1.9 DNA
(Dewhurst et al., 1990) using primers 5′-CCGGAATTCG5280-
AGCCATGTCAGATC5294-3′ (forward, nt position in parental
isolate PBj14, GenBank accession no. M80193) and 5′-
CCGCTCGAGTCATTATGTCC-3′ (reverse, binding down-
stream of nt 5625). The amplification product spanning the
vpx gene was inserted into the mammalian expression vector
pcDNA3.1(+) (Invitrogen, Carlsbad, CA, USA) using the
restriction sites EcoRI and XhoI. The expression construct for
HA-tagged Vpx designated pHA-vpx was generated likewise
but using primers 5′-CCCATGAATTCATGTATCCATATG-
ATGTTCCAGATTATGCTT5288CAGATCCCAGGGAG-
AG5304-3′ (forward) and 5′-CCGATCTCGAG5658TGGGG-
CTTCATCTTATGGAGGTC5635-3′ (reverse).
For the generation of pHIV-LC-EGFP containing the Vpx
binding domain of SIVsmmPBj p6, an 87-bp fragment
encompassing aa 22–50 of SIVsmmPBj p6 was amplified,
fused to the respective flanking sequences of HIV-1 p6 (the 5′
flanking sequence comprised aa 1–17, the 3′ flanking sequence
aa 19–52 of HIV-1 p6), and introduced into pNL4-3ΔE-EGFP
(Muhlebach et al., 2005) via SpeI and SbfI.
Details of primers and PCR conditions are available upon
request. Correct cloning of all constructs was confirmed by
DNA sequence analysis (MWG Biotech, Ebersberg, Germany).
Cell lines and arrest of cells
293Tcells (ATCC; SD 3515), HT1080 cells (ATCC;CCL121),
and human diploid fibroblasts strain α-1 (Neumann-Haefelin
et al., 1983) were maintained in Dulbecco's modified Eagle's
medium (DMEM) supplemented with penicillin (100 U/ml),
streptomycin (100 μg/ml), L-glutamine (2 mM), and 10%
FCS. Human osteosarcoma cell line-derived GHOST/CD4-
CXCR4 cells stably transfected with an HIV-1 LTR-EGFP
expression construct were grown in DMEM with supplements
as described (Cecilia et al., 1998).
GHOST/CD4-CXCR4 or α-1 cells were arrested in the G1/S-
phase of the cell cycle by aphidicolin (10 μg/ml), or in the G0-
phase by serum starvation (0.4% FCS in DMEM) as described
(Muhlebach et al., 2005). To arrest GHOST/CD4-CXCR4 cells
in G0, 200 mM ethanol was also added during the last 24 h
before transduction. Successful arrest was assessed by determi-
nation of the DNA content as described (Merrill, 1998;
Muhlebach et al., 2005).
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For generation of SIVsmmPBj-derived vectors, 293T cells
were co-transfected with one of the vector encoding plasmids
described above and pMD.G (Ory et al., 1996) coding for the
vesicular stomatitis virus glycoprotein (VSV-G) using Lipo-
fectamine Plus (Invitrogen) transfection reagent. HIV-1-derived
vectors were generated likewise but using env-deleted HIV-1
vector encoding plasmids pNL4-3Δenv or pNL4-3ΔE-EGFP
(Muhlebach et al., 2005). MLV-derived vectors were generated
by triple transfection of 293T cells with transfer vector
pMgSLdelS-lacZ (Steidl et al., 2002), the packaging construct
pHit60 (Soneoka et al., 1995) and pMD.G. Forty-eight hours
later, the vector containing supernatants were collected, fil-
trated through a 0.45-μm filter (Sartorius, Göttingen, Ger-
many), and subsequently stored at −80 °C. If required, vectors
were purified and concentrated by ultracentrifugation
(125,000×g, 2 h, 4 °C) through a 20% sucrose cushion. For
titration, vectors were added in serial dilutions to target cells
HT1080, GHOST/CD4-CXCR4, or α-1 cells cultured in 12- or
24-well plates. After 4 h, medium was exchanged. Additional
48 h later, cells were analyzed for expression of viral proteins
or marker genes.
Expression of marker genes egfp or lacZ was monitored by
fluorescence microscopy or by X-Gal staining (Mikawa et al.,
1991), respectively. Gene transfer by vectors not encoding a
marker gene was monitored as described previously (Muhle-
bach et al., 2005) either on GHOST/CD4-CXCR4 cells by Tat-
dependent expression of endogenous EGFP, or on α-1 or
HT1080 cells by staining of viral proteins using an in situ
immunoperoxidase assay (IPA). For the detection of HIV-1 and
SIVsmmPBj proteins, sera of HIV-1-infected patients and a
cross-reactive serum of an HIV-2-infected patient, respectively,
were applied at 1:400 dilutions. The horseradish peroxidase
(HRP)-coupled secondary antibody against human IgG (Sigma,
St. Louis, USA) was used at 1:500 dilution.
Isolation and transduction of primary human monocytes
Primary human CD14+ monocytes were isolated from puri-
fied PBMC from healthy donors by negative depletion
employing magnetic activated cell sorting (MACS) using the
Monocyte Isolation Kit II (Miltenyi Biotec, Bergisch Gladbach,
Germany). Purity of isolated monocytes was assessed by flow
cytometry (FACScan, Becton Dickinson) for expression of
monocyte markers CD14 and CD86 using phycoerythrin-
conjugated mAbs directed against CD14 or fluorescein
isothiocyanate-conjugated mAbs against CD86 (both BD
Bioscience, Heidelberg, Germany). Monocytes were plated at
a density of 1×105 cells/well into 48-well tissue culture plates
(BD Falcon, Bedford, MA, USA) and were maintained in RPMI
1640 supplemented with L-glutamine (2 mM), 0.5% FCS, and
10% autologous donor serum.
On the desired day after isolation, monocytes or monocyte
derived macrophages were washed and exposed for 8 h to
vectors at the desired multiplicity of infection (moi), as
standardized on HT1080 cells. Cells were washed thoroughlyand fresh medium was added. After 7 days, EGFP expression
was monitored by fluorescence microscopy.
Western blot analysis
Vector containing supernatants were clarified through a 0.45-
μm filter and concentrated by ultracentrifugation through a 20%
sucrose cushion (125,000×g, 2 h, 4 °C). Pellets were resus-
pended in TLB-lysis buffer (20 mM Tris–HCl [pH 7.4],
137 mM NaCl, 2 mM EDTA, 50 mM glycerol-2-phosphate
disodium salt, 1% glycerol, 1% Triton X-100) supplemented
with protease inhibitor cocktail (Roche, Mannheim, Germany).
Samples were denatured by boiling and separated on NuPAGE
Novex 4–12% Bis–Tris Gels (Invitrogen). Following electro-
phoresis, proteins were transferred to Hybond ECL nitrocellu-
lose membrane (Amersham Pharmacia, NJ, USA) by
electroblotting, incubated in blocking buffer (5% nonfat dry
milk in TBST) at room temperature for 1 h and then overnight at
4 °C with the appropriate primary antibody. Anti-HIV-2-Vpx
monoclonal 6D2.6 (NIH AIDS Research and Reference
Reagent Program, Rockville, USA) (Kappes et al., 1993) was
used at a dilution of 1:50. We and others (Mahalingam et al.,
2001) observed cross-reactivity to Vpx of SIVsmmPBj. Anti-
HIV-2-Nef rat monoclonal Hom-HB5 (Fackler et al., 1996),
anti-SIV-Vif rabbit immune serum (Liu et al., 1995), and anti
HIV-1-Gag p24 183-H12-5C monoclonal antibody (NIH AIDS
Research and Reference Reagent Program, Rockville, USA)
(Chesebro et al., 1992) were used at dilutions of 1:50. Anti-SIV-
Gag p27 monoclonal KK60 (NIBSC Centralised Facility for
AIDS Reagents, Hertfordshire, UK) (Newman et al., 1995) was
used at a dilution of 1:100, anti SIV-Vpr rabbit immuneserum
was used at a dilution of 1:500, and anti-HA monoclonal
antibody (Covance, Princeton, NJ, USA) was used at a dilution
of 1:1000. Anti-VSV-G monoclonal antibody P5D4 (Sigma)
was used at a dilution of 1:10,000. Protein-bound antibodies
were probed with respective HRP-conjugated specific second-
ary antibodies (at 1:2500 or 1:7500 dilutions, respectively),
washed thoroughly and developed using the enhanced chemi-
luminescence detection system (Amersham Pharmacia).
PCR assays
To analyze the fate of vector genomes, genomic DNA was
isolated from transduced or control cells using the DNeasy
Tissue Kit (Qiagen, Hilden, Germany) and amplified by PCR
for detection of various proviral DNA forms as described
previously (Muhlebach et al., 2005). Briefly, for the detection of
integrated vector sequences, a two-step Alu PCR assay was
performed, in the first step using primers that bind to genomic
Alu and proviral sequences, and in the second round of
amplification using only virus-specific primers leading to a 246-
bp fragment. Two-LTR circles were detected in a single-round
PCR by amplification of an 806-bp fragment spanning the LTR/
LTR junction in two-LTR circles. To prove the presence of
vector DNA of any form (free linear, circular, or integrated) as
an indicator for reverse transcription, a fragment of the egfp
gene was amplified. Monocytes were transduced with DNase-
340 N. Wolfrum et al. / Virology 364 (2007) 330–341treated vector supernatants (20 U of DNase I/ml for 1 h), and
DNAwas harvested 4 h post transduction. Detailed information
about primer sequences is available upon request.
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